All News

One survivor reflects on life after cancer on "cannoli Monday."

As 2019 comes to a close, take a read through CURE®’s top stories of the year.

One male breast cancer survivor reflects on revolutionary developments from the San Antonio Breast Cancer Symposium.

Sometimes the imperfections in life can bring an unexpected beauty. A famous mystery author explores this idea.

The Food and Drug Administration’s accelerated approval of Padcev offers patients with advanced bladder cancer a potential standard of care.

An improved app sends clinical trials straight to the phone of this patient with breast cancer (and she can forward them right to her doctor).

Take a look back at the top 10 podcasts of 2019 – and be sure to subscribe so you don’t miss an episode in 2020.

If you’ve experienced neuropathy, you know what it entails.

A diagnosis of breast cancer can cause a person to become very fearful especially when the future holds so many unknowns, but it’s not healthy to live under an umbrella of fear. In this article, survivor, Bonnie Annis, shares her experience.

The author uses a well-known story about landing in another country to explain cancer journeys.

A two-time cancer survivor suggests simplifying the holidays when coping with cancer.

Falls are a risk for everyone during slushy winter months, but the risk is especially high for people with cancer. Memorial Sloan Kettering physical therapist Jillian Hobson walks readers through what they can do to minimize the chance of falling.

Men with metastatic castration-sensitive prostate cancer will now have a fourth treatment option to consider.

A male breast cancer survivor examines the invisibility factor in this disease.

Patients with unresectable or metastatic HER2-positive breast cancer now have a new treatment option.

They're billed as "nothing", but for this patient with cancer, the tattoos are daily reminders of her new life.

From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.

One patient provides potential caregivers “a guide to help you help me”.

The Food and Drug Administration approved Padcev for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have received prior treatment with a PD-1/PD-L1 inhibitor and platinum-containing chemotherapy.

Radiofrequency ablation was statistically on par with surgery when it came to survival after an early recurrence of liver cancer, but surgery provided more benefit if the disease was a bit more advanced.

Some beauty products could contain harmful ingredients. For the person with cancer, it’s important to know which options are the safest.

One expert discusses exciting advances in using drug combinations to treat metastatic melanoma.

Whether we have cancer or not, gratitude enriches our lives and there are many things to be grateful for.

Patients with hepatocellular carcinoma whose tumors couldn’t be surgically removed lived longer and experienced few side effects after stereotactic body radiotherapy, according to phase 2 study findings.

The Food and Drug Administration approved Xtandi for the treatment of patients with metastatic castration-sensitive prostate cancer.

Fast track designation has been granted for the investigational therapy tipifarnib to treat patients with HRAS mutant head and neck squamous cell carcinomas.

Two-time cancer survivor gratefully shares her gratitude and discusses how they are getting better at helping cancer patients.

Patients with head and neck cancer who received acupuncture during therapy saw lower incidence and severity of dry mouth compared with those who received oral health education.

Two-time cancer survivor reviews some of the questions about genetic testing for other cancer survivors.